Page 113 - 南京医科大学自然版

第44卷第4期 胡永灿，吕 凌. 腺嘌呤核苷酸转位酶：生理功能及在疾病发生中的病理意义［J］.
2024年4月 南京医科大学学报（自然科学版），2024，44（04）：546-552，566 ·551 ·

carrier inhibition in renal proximal tubule epithelial cells verse bioenergetic effects of N⁃acyl amino acids in human
［J］. Arch Toxicol，2023，97（7）：1927-1941 adipocytes overshadow beneficial mitochondrial uncou⁃
［3］ XIAO P，CHEN X，DONG Z，et al. BNIP3 overexpression pling［J］. Redox Biol，2023，66：102874
may promote myeloma cell apoptosis by enhancing sensi⁃ ［16］ NESCI S. Proton leak through the UCPs and ANT carriers
tivity to bortezomib via the p38 MAPK pathway［J］. He⁃ and beyond：a breath for the electron transport chain［J］.
matology，2023，28（1）：2231739 Biochimie，2023，214（Pt B）：77-85
［4］ GREL H，WOZNICA D，RATAJCZAK K，et al. Mitochon⁃ ［17］ BRAND M D，PAKAY J L，OCLOO A，et al. The basal
drial dynamics in neurodegenerative diseases：unraveling proton conductance of mitochondria depends on adenine
the role of fusion and fission processes［J］. Int J Mol Sci， nucleotide translocase content［J］. Biochem J，2005，392
2023，24（17）：13033 （Pt 2）：353-362
［5］ JI C，ZHANG Z，LI Z，et al. Mitochondria⁃associated en⁃ ［18］ SHABALINA I G，KRAMAROVA T V，NEDERGAARD
doplasmic reticulum membranes：inextricably linked with J，et al. Carboxyatractyloside effects on brown ⁃ fat mito⁃
autophagy process［J］. Oxid Med Cell Longev，2022， chondria imply that the adenine nucleotide translocator
2022：7086807 isoforms ANT1 and ANT2 may be responsible for basal
［6］ RUPRECHT J J，KUNJI E R S. The SLC25 mitochondrial and fatty⁃acid⁃induced uncoupling respectively［J］. Bio⁃
carrier family：structure and mechanism［J］. Trends Bio⁃ chem J，2006，399（3）：405-414
chem Sci，2020，45（3）：244-258 ［19］ PESTEL J，BLANGERO F，WATSON J，et al. Adipokines
［7］ CHEN Y，WU L，LIU J，et al. Adenine nucleotide translo⁃ in obesity and metabolic⁃related⁃diseases［J］. Biochimie，
case：current knowledge in post ⁃ translational modifica⁃ 2023，212：48-59
tions，regulations and pathological implications for human ［20］MORROW R M，PICARD M，DERBENEVA O，et al. Mi⁃
diseases［J］. FASEB J，2023，37（6）：e22953 tochondrial energy deficiency leads to hyperproliferation
［8］ RUPRECHT J J，KING M S，ZÖGG T，et al. The molecu⁃ of skeletal muscle mitochondria and enhanced insulin
lar mechanism of transport by the mitochondrial ADP/ sensitivity［J］. Proc Natl Acad Sci USA，2017，114（10）：
ATP carrier［J］. Cell，2019，176（3）：435-447 2705-2710
［9］ OGUNBONA O B，CLAYPOOL S M. Emerging roles in ［21］MOON J S，DA CUNHA F F，HUH J Y，et al. ANT2 drives
the biogenesis of cytochrome c oxidase for members of proinflammatory macrophage activation in obesity［J］. JCI
the mitochondrial carrier family［J］. Front Cell Dev Biol， Insight，2021，6（20）：e147033

2019，7：3 ［22］ GELONEZE B，VASQUES A C J，STABE C F C，et al.
［10］HARBORNE S P D，KUNJI E R S. Calcium⁃regulated mi⁃ HOMA1⁃IR and HOMA2⁃IR indexes in identifying insu⁃
tochondrial ATP⁃Mg/Pi carriers evolved from a fusion of lin resistance and metabolic syndrome：Brazilian Metabol⁃
an EF⁃hand regulatory domain with a mitochondrial ADP/ ic Syndrome Study（BRAMS）［J］. Arquivos Brasileiros
ATP carrier⁃like domain［J］. IUBMB Life，2018，70（12）： De Endocrinol E Metabol，2009，53（2）：281-287
1222-1232 ［23］ ESLAM M，NEWSOME P N，SARIN S K，et al. A new
［11］MONTALVO⁃ACOSTA J J，KUNJI E R S，RUPRECHT J definition for metabolic dysfunction⁃associated fatty liver
J，et al. Structure，substrate binding，and symmetry of the disease：an international expert consensus statement［J］.
mitochondrial ADP/ATP carrier in its matrix⁃open state［J］. J Hepatol，2020，73（1）：202-209
Biophys J，2021，120（23）：5187-5195 ［24］RINELLA M E，NEUSCHWANDER ⁃ TETRI B A，SID⁃
［12］ RUPRECHT J J，KUNJI E R. Structural changes in the DIQUI M S，et al. AASLD Practice Guidance on the clinical
transport cycle of the mitochondrial ADP/ATP carrier［J］. assessment and management of nonalcoholic fatty liver
Curr Opin Struct Biol，2019，57：135-144 disease［J］. Hepatology，2023，77（5）：1797-1835
［13］MISHRA G，COYNE L P，CHEN X J. Adenine nucleotide ［25］TENG M L，NG C H，HUANG D Q，et al. Global incidence
carrier protein dysfunction in human disease［J］. IUBMB and prevalence of nonalcoholic fatty liver disease［J］.
Life，2023，75（11）：911-925 Clin Mol Hepatol，2023，29（Suppl）：S32-S42
［14］ ZAIB S，HAYYAT A，ALI N，et al. Role of mitochondrial ［26］CHO J，ZHANG Y，PARK S Y，et al. Mitochondrial ATP
membrane potential and lactate dehydrogenase a in apop⁃ transporter depletion protects mice against liver steatosis
tosis［J］. Anticancer Agents Med Chem，2022，22（11）： and insulin resistance［J］. Nat Commun，2017，8：14477
2048-2062 ［27］ZHANG P F，CHENG X Y，SUN H M，et al. Atractyloside
［15］HERRNHOLD M，HAMP I，PLETTENBURG O，et al. Ad⁃ protect mice against liver steatosis by activation of autopha⁃